Moelis Shorts Ease as Analysts Trim Targets

Among the independent advisory names heading into earnings today, MC carries one of the lighter short footprints in its peer group. PJT and EVR have both outpaced Moelis on the week, up 4.9% and 3.8% respectively against MC's 3.8% gain, while LAZ led the group at 5.9%. Short interest on MC has actually been retreating sharply, falling nearly 15% over the past week to 6.9% of the free float, a meaningful pullback from mid-October levels above 8% of float implied by the history. Borrow conditions confirm the story: availability is running at roughly 1,074%, meaning more than ten times as many shares are available to lend as are currently borrowed, and the cost to borrow is just 0.40%, barely above zero. Options positioning is modestly more cautious than average, with the put/call ratio at 0.55 against a 20-day mean of 0.45, but the z-score of 0.94 puts that well within normal range.

The analyst community has spent October marking down targets without changing its broader view. JP Morgan cut its target to $68 from $70 on the day of the print while holding Neutral, and Goldman Sachs trimmed to $62 from $71 earlier this month. Morgan Stanley, which holds an Overweight, lowered its target to $77 from $85 in early October. UBS moved in the opposite direction on rating, upgrading to Neutral from Sell while keeping its target near $59. The consensus mean of $67.30 implies roughly 20% upside from yesterday's close of $55.88, but the direction of travel among most firms has been downward through the quarter. The bull case rests on a record pipeline and strong sequential revenue momentum reported last quarter, when revenue hit $307 million, up 41% from the prior period. Bears point to a softer sponsor backlog, delays in deal closings, and the sensitivity of advisory fees to any renewed M&A freeze.

Institutional ownership data shows BlackRock added around 647,000 shares in the quarter to September 30, lifting its stake to 12.2% of shares outstanding, the largest position on the register. Columbia Management and Charles Schwab both added meaningfully in the same period. Kayne Anderson Rudnick, the second-largest holder, trimmed by 50,000 shares as of June and has since filed a 13G/A reducing its disclosed stake to 7.9% from 9.1%, though that filing dates to May and the current position may differ. The activist register carries no 13D filers; all holders with disclosed positions above 5% are passive. Insider activity in the trailing 90 days has been dominated by small compensation grants, with net sales of roughly 6,700 shares worth around $466,000, not a scale that carries much signal.

Wikipedia attention for Moelis spiked to a z-score of 3.3 against its own trailing 90-day history around October 10, the highest retail attention reading in the alt data set, though the dataset has not been measured to lead any of the company's reported financial figures, so it reflects elevated interest rather than anything more specific. The print tonight will test whether the record pipeline management described last quarter has translated into closed fees, and whether advisory revenue can sustain the momentum that made Q2 such a strong beat against a backdrop of still-cautious M&A conditions.